Health Ministry guidelines on the use of Ivermectin for the treatment of covid patients differ with the WHO

The Union Ministry of Health has recommended the drugs – ivermectin and remediesvir in the Covid-19 treatment after the World Health Organization (WHO) warned against the use of these drugs in the treatment of coronavirus-infected patients.

“Safety and efficacy are important when using any drug for a new indication. WHO recommends against the use of ivermectin for COVID-19 except in clinical trials,” recently WHO’s chief scientist Saumya Swaminathan tweeted.

Remedisavir is a broad-spectrum antiviral drug originally intended to treat Ebola. And ivermectin is used to treat parasitic infections such as head lice, itching, and river blindness.

Earlier this month, the revised guidelines issued by the All India Institute of Medical Sciences (AIIMS) on the use of Remedisvir and Ivermectin recommended that Remedisivir be considered under special circumstances if the patient is in moderate to severe oxygen support. is required. Injections must be made within 10 days of the positive test result. It states that the injection is not intended for home use or for anyone who is not on oxygen support.

The recommended dose is 200 mg IV on the first day and 100 mg IV for the next four days. The guidelines do not specify any medication for patients with moderate disease. And for cases of mild or domestic isolation, ivermectin may be given provided it is HCQ tablets with a dose of 200 mcg / kg once a day for three days or 400 mg for one day and 400 mg for four days .

On Wednesday, the Tamil Nadu government issued revised guidelines, and the department also recommended ivermectin, paracetamol, vitamin C, zinc and other drugs for patients with over 96 saturation. The government said that patients who maintain saturation above 92 for three days can be discharged.